CART protects brain from damage through ERK activation in ischemic stroke

Neuropeptides

Volumn 42, Issue 5-6, 2008, Pages 653-661

  Jia, Jia ^a,b   Chen, Xuemei ^a   Zhu, Wenjing ^a   Luo, Yun ^a   Hua, Zichun ^b   Xu, Yun ^a,b  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

CART; MAPK ERK; siRNA; Stroke

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; GLUCOSE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OXYGEN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; BRAIN DAMAGE; BRAIN PROTECTION; CELL DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; BASE SEQUENCE; BRAIN ISCHEMIA; CELL DEATH; CELLS, CULTURED; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; RNA, SMALL INTERFERING; STROKE;

EID: 56649097457     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2008.05.006     Document Type: Article

References (28)

1. Adams L.D., Gong W., Vechia S.D., Hunter R.G., and Kuhar M.J. CART: from gene to function. Brain Res. 848 (1999) 137-140
2. Belcheva M.M., and Coscia C.J. Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase. Neurosignals 11 (2002) 34-44
3. Dall V.S., Lambert P.D., Couceyro P.C., Kuhar M.J., and Smith Y. CART peptide immunoreactivity in the hypothalamus and pituitary in monkeys: analysis of ultrastructural features and synaptic connections in the paraventricular nucleus. J. Comp. Neurol. 416 (2000) 291-308
4. Dong W., Jin G.H., Li S.F., Sun Q.M., Ma D.Y., and Hua Z.C. Cross-linked polyethylenimine as potential DNA vector for gene delivery with high efficiency and low cytotoxicity. Acta Biochim. Biophys. Sin. (Shanghai) 38 (2006) 780-787
5. Douglass J., McKinzie A.A., and Couceyro P. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J. Neurosci. 15 (1995) 2471-2481
6. Dun S.L., Ng Y.K., Brailoiu G.C., Ling E.A., and Dun N.J. Cocaine- and amphetamine-regulated transcript peptide-immunoreactivity in adrenergic C1 neurons projecting to the intermediolateral cell column of the rat. J. Chem. Neuroanat. 23 (2002) 123-132
7. Hansen M.B., Nielsen S.E., and Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119 (1989) 203-210
8. Hubert G.W., and Kuhar M.J. Colocalization of CART with substance P but not enkephalin in the rat nucleus accumbens. Brain Res. 1050 (2005) 8-14
9. Hubert G.W., and Kuhar M.J. Colocalization of CART peptide with prodynorphin and dopamine D1 receptors in the rat nucleus accumbens. Neuropeptides 40 (2006) 409-415
10. Kuhar M.J., Adams L.D., Hunter R.G., Vechia S.D., and Smith Y. CART peptides. Regul. Peptides 89 (2000) 1-6
11. Lakatos A., Prinster S., Vicentic A., Hall R.A., and Kuhar M.J. Cocaine- and amphetamine-regulated transcript (CART) peptide activates the extracellular signal-regulated kinase (ERK) pathway in AtT20 cells via putative G-protein coupled receptors. Neurosci. Lett. 384 (2005) 198-202
12. Li S., Dong W., Zong Y., Yin W., Jin G., Hu Q., Huang X., Jiang W., and Hua Z.C. Polyethylenimine-complexed plasmid particles targeting focal adhesion kinase function as melanoma tumor therapeutics. Mol. Ther. 15 (2007) 515-523
13. Louis JCM, 1996. Methods of preventing neuron degeneration and promoting neuron regeneration. Amgen, International patent application, publication number WO96/34619.
14. Mao P., Ardeshiri A., Jacks R., Yang S., Hurn P.D., and Alkayed N.J. Mitochondrial mechanism of neuroprotection by CART. Eur. J. Neurosci. 26 (2007) 624-632
15. Risold P.Y., Bernard-Franchi G., Collard C., Jacquemard C., La R.A., and Griffond B. Ontogenetic expression of CART-peptides in the central nervous system and the periphery: a possible neurotrophic role. Peptides 27 (2006) 1938-1941
16. Sarkar S., Wittmann G., Fekete C., and Lechan R.M. Central administration of cocaine- and amphetamine-regulated transcript increases phosphorylation of cAMP response element binding protein in corticotropin-releasing hormone-producing neurons but not in prothyrotropin-releasing hormone-producing neurons in the hypothalamic paraventricular nucleus. Brain Res. 999 (2004) 181-192
17. Smith Y., Kieval J., Couceyro P.R., and Kuhar M.J. CART peptide-immunoreactive neurones in the nucleus accumbens in monkeys: ultrastructural analysis, colocalization studies, and synaptic interactions with dopaminergic afferents. J. Comp. Neurol. 407 (1999) 491-511
18. Smith Y., Koylu E.O., Couceyro P., and Kuhar M.J. Ultrastructural localization of CART (cocaine- and amphetamine-regulated transcript) peptides in the nucleus accumbens of monkeys. Synapse 27 (1997) 90-94
19. Stein J., Steiner D.F., and Dey A. Processing of cocaine- and amphetamine-regulated transcript (CART) precursor proteins by prohormone convertases (PCs) and its implications. Peptides 27 (2006) 1919-1925
20. Vicentic A., Lakatos A., and Jones D. The CART receptors: background and recent advances. Peptides 27 (2006) 1934-1937
21. Vrang N., Larsen P.J., Kristensen P., and Tang-Christensen M. Central administration of cocaine-amphetamine-regulated transcript activates hypothalamic neuroendocrine neurons in the rat. Endocrinology 141 (2000) 794-801
22. Werry T.D., Christopoulos A., and Sexton P.M. Mechanisms of ERK1/2 regulation by seven-transmembrane-domain receptors. Curr. Pharm. Des. 12 (2006) 1683-1702
23. Wu B., Hu S., Yang M., Pan H., and Zhu S. CART peptide promotes the survival of hippocampal neurons by upregulating brain-derived neurotrophic factor. Biochem. Biophys. Res. Commun. 347 (2006) 656-661
24. Xu Y., and Tao Y.X. Involvement of the NMDA receptor/nitric oxide signal pathway in platelet-activating factor-induced neurotoxicity. Neuroreport 15 (2004) 263-266
25. Xu Y., Traystman R.J., Hurn P.D., and Wang M.M. Membrane restraint of estrogen receptor alpha enhances estrogen-dependent nuclear localization and genomic function. Mol. Endocrinol. 18 (2004) 86-96
26. Xu Y., Zhang B., Hua Z., Johns R.A., Bredt D.S., and Tao Y.X. Targeted disruption of PSD-93 gene reduces platelet-activating factor-induced neurotoxicity in cultured cortical neurons. Exp. Neurol. 189 (2004) 16-24
27. Xu Y., Zhang W., Klaus J., Young J., Koerner I., Sheldahl L.C., Hurn P.D., Martinez-Murillo F., and Alkayed N.J. Role of cocaine- and amphetamine-regulated transcript in estradiol-mediated neuroprotection. Proc. Natl. Acad. Sci.USA 103 (2006) 14489-14494
28. 2+ signaling in hippocampal neurons. J. Neurosci. 21 (2001) 7474-7480